Home > Healthcare > Enteral Feeding Tubes Market > Table of Contents

Enteral Feeding Tubes Market – By Product (Nasoenteric/Nasal [Nasogastric, Nasojejunal], Abdominal/Ostotomy [Gastrostomy]), Disease Condition (Cancer, CNS & Mental Health), Patient (Adult, Pediatric), Tube Type, Tube Placement, End-use & Forecast, 2024 – 2032

  • Report ID: GMI4846
  • Published Date: Aug 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Increase in number of cancer cases across the globe

3.2.1.2    Rise in incidence of premature births and pediatric diseases

3.2.1.3    Growing central nervous system and mental health disorders

3.2.1.4    Increasing metabolic disorders

3.2.1.5    Recent technological advancements

3.2.1.6    Rise in adoption of home healthcare

3.2.2    Industry pitfalls & challenges

3.2.2.1    Lack of awareness in developing and under-developed regions

3.2.2.2    Risks associated with enteral feeding

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Gap analysis

3.6    Technology landscape

3.7    Porter's analysis

3.8    PESTEL analysis

3.9    Future market trends

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Company market share analysis

4.4    Competitive positioning matrix

4.5    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Nasoenteric/nasal feeding tube

5.2.1    Nasogastric tube

5.2.2    Nasojejunal tube

5.3    Abdominal/ostomy feeding tube

5.3.1    Gastrostomy tube

5.3.2    Jejunostomy/jejunal tube

5.3.3    Gastrojejunal (GJ) or transjejunal tube

Chapter 6   Market Estimates and Forecast, By Disease Condition, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Cancer

6.2.1    Head and neck cancer

6.2.2    Gastrointestinal cancer

6.2.3    Other cancers

6.3    Central nervous system (CNS) & mental health

6.4    Non-malignant gastrointestinal (GI) disorders

6.5    Other disease conditions

Chapter 7   Market Estimates and Forecast, By Patient, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Adult

7.3    Pediatric

Chapter 8   Market Estimates and Forecast, By Tube Type, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    Short term feeding tube

8.3    Long term feeding tube

8.4    Temporary feeding tube

Chapter 9   Market Estimates and Forecast, By Tube Placement, 2021 – 2032 ($ Mn)

9.1    Key trends

9.2    Without surgery

9.3    Surgical placement

9.4    Endoscopic placement

Chapter 10   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)

10.1    Key trends

10.2    Home care

10.3    Hospitals

10.4    Other end-users

Chapter 11   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

11.1    Key trends

11.2    North America

11.2.1   U.S.

11.2.2   Canada

11.3    Europe

11.3.1   Germany

11.3.2   UK

11.3.3   France

11.3.4   Spain

11.3.5   Italy

11.3.6   Netherlands

11.3.7   Rest of Europe

11.4    Asia Pacific

11.4.1   China

11.4.2   Japan

11.4.3   India

11.4.4   Australia

11.4.5   South Korea

11.4.6   Rest of Asia Pacific

11.5    Latin America

11.5.1   Brazil

11.5.2   Mexico

11.5.3   Argentina

11.5.4   Rest of Latin America

11.6    Middle East and Africa

11.6.1   South Africa

11.6.2   Saudi Arabia

11.6.3   UAE

11.6.4   Rest of Middle East and Africa

Chapter 12   Company Profiles

12.1    Abbott Laboratories

12.2    Applied Medical Technology, Inc.

12.3    Avanos Medical, Inc.

12.4    B. Braun Melsungen AG

12.5    Becton, Dickinson and Company

12.6    Boston Scientific Corporation

12.7    C.R. Bard, Inc.

12.8    Cardinal Health

12.9    CONMED Corporation

12.10    Cook Medical

12.11    Danone S.A.

12.12    Fresenius Kabi AG

12.13    Medline Industries, Inc.

12.14    MOOG Inc.

12.15    Vygon
 

Authors: Mariam Faizullabhoy , Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 307
  • Countries covered: 23
  • Pages: 110
 Download Free Sample